Q1.
How many breast augmentation procedures do you perform on average each month?
Q2.
How would you best describe your practice?
Q3.
How many breast augmentation procedures did you perform / expect to perform in:
Q4.
Do you see any impact of concerns about the economy on your procedure volumes? Please be specific.
Q5.
What proportion of breast augmentation procedures do you currently perform with each product?
- Allergan Silicone
- Allergan Saline
- Mentor Silicone
- Mentor Saline
- Sientra Silicone
- Ideal Saline
- Other
Q6.
What proportion of breast augmentation procedures do you expect to perform with each product in 1 year?
- Allergan Silicone
- Allergan Saline
- Mentor Silicone
- Mentor Saline
- Sientra Silicone
- Ideal Saline
- Other
Q7.
Which of the following is your preferred implant?
- Ideal Saline
- Allergan Silicone
- Mentor Silicone
- Sientra Silicone
- Allergan Saline
Q8.
Please elaborate on your implant preference.
Q9.
What is your impression of the Motiva implant from Establishment Labs, including the reported safety data?
Q10.
Assuming the Motiva implant is approved by the US FDA, what proportion of breast augmentation procedures do you anticipate performing with each product In 1 year following approval?
- Allergan Silicone
- Allergan Saline
- Mentor Silicone
- Mentor Saline
- Sientra Silicone
- Ideal Saline
- Other
Q11.
Assuming the Motiva implant is approved by the US FDA, what proportion of breast augmentation procedures do you anticipate performing with each product In 3 years following approval?
- Allergan Silicone
- Allergan Saline
- Mentor Silicone
- Mentor Saline
- Sientra Silicone
- Ideal Saline
- Other
Q12.
Assuming the Motiva implant is approved by the US FDA, what proportion of breast augmentation procedures do you anticipate performing with each product In 5 years following approval?
- Allergan Silicone
- Allergan Saline
- Mentor Silicone
- Mentor Saline
- Sientra Silicone
- Ideal Saline
- Other
Q13.
What do you think of the minimally invasive breast augmentation procedure under development by Establishment Labs?
Q14.
If it receives marketing authorization in the US, what proportion (%) of augmentation procedures would you consider good candidates for the Motiva Mia minimally invasive procedure?
Q15.
Lastly, please rank the following factors for patient implant selection in your practice (where 1 is the most influential, etc.).